Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
PaperCitations, authors & open-access status
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 213 citations, 2020 year and hybrid oa status.
213
Citations
2020
Year
hybrid
OA Status